Montreal Cognitive Assessment (MoCA) no rastreio de comprometimento cognitivo leve (CCL) em pacientes com doença renal crônica (DRC) pré-dialítica
Loading...
Date
Journal Title
Journal ISSN
Volume Title
Publisher
-
Abstract
Introduction: Individuals with chronic kidney disease (CKD) are at higher risk of
developing cognitive impairment (CI), initially mild (MCI), potentially identifiable,
but still poorly diagnosed and treated. The Montreal Cognitive Assessment (MoCA)
has been indicated for MCI screening in CKD. Objective: To assess MCI in patients
with CKD not yet on dialysis. Methods: Study conducted in 72 non-elderly subjects
with pre-dialysis CKD. The neuropsychological assessment included: The global
cognitive assessment test MoCA; the clock drawing (CD); the digit span forward (DSF)
and reverse (DSR); phonemic verbal (VF) fluency (FAS) and semantics (animals); the
fist-edge-palm (FEP); and the memory 10 pictures. Results: The average age of the
participants was 56.74 ± 7.63 years, with predominance of male sex (55.6%), mainly
with ≥ 4 years of education (84.3%), with CKD cathegories 1, 2 and 3a and 3b
(67.6%), hypertension (93.1%) and diabetes mellitus (52.1%). MCI (MoCA ≤ 24)
was observed in 73.6% of the patients. We did not find association among MCI
with demographic and clinical variables, but a tendency to association with age (p =
0.07), educational level (p = 0.06) and diabetes (0.06). The executive function tests
CD, DS-reverse and FEP, individually were able to identify CI with good sensibility
and negative predictive value compared to MoCA and together, showed the same
capability to identify MCI when compared to MoCA. Conclusion: The MCI is common
in non-elderly patients with CKD not yet on dialysis. Together, the CD, DSR and
FEP showed similar performance in identify MCI in this population when compared
to MoCA, suggesting impairment of executive functions.
Description
Citation
Collections
Endorsement
Review
Supplemented By
Referenced By
Rights and licensing
Acesso Aberto
